Luma Group
Themasap Khan, PhD, is a seasoned professional in the biotech investment sector, currently serving as Co-Founder at Luma Group since January 2023. Prior experience includes a tenure at Civilization Ventures from October 2018 to December 2024, where contributions as Senior Advisor involved diligence, investment, and growth of emerging companies such as Rewrite Therapeutic and BillionToOne, among others. Additionally, Themasap Khan held the roles of Vice President and Founding Associate at Civilization Ventures, playing a pivotal role in establishing the firm as an early-stage biotech leader. Academic credentials include a PhD from Stanford University School of Medicine and a BS from New York University.
This person is not in any teams
This person is not in any offices